Molecular characterization of HLA-class-I expression was investigated in human tumor cell lines at the protein and mRNA levels using locus-specific monoclonal antibodies (MAbs) and probes. Some cell lines exhibited a differential expression of HLA-A and HLA-B products and also showed differences in
The level of expression of class-I MHC antigens in adenovirus-transformed human cell lines
โ Scribed by Roger J. A. Grand; Martin Rowe; Philip J. Byrd; Phillip H. Gallimore
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- French
- Weight
- 994 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
The level of expression of the class-I major histocompatibil-19 and 54kDa. The El region encompasses those viral genes ity (MHC) antigen was determined in a series of human em-expressed first following lytic infection and is also that area bryo cell lines transformed with either adenovirus I2 (Ad 12) responsible for the acquisition and maintenance of the transearly region ' (El) Or adenovirus formed phenotype (for reviews see Bernards and van der Eb, 1987). activated N-ras DNA. MHC class-I antigen expression was greatly reduced in all Ad I 2 transformants, compared to primary cells. Expression was also reduced in the Ad 5 cell lines In view of the interesting data obtained with adenovirustransformed with E I A and EIB DNA, but levels were near transformed rodent cell systems, we have undertaken an extennormal in those lines with only E I A D N A present. Amounts sive investigation of the level of expression of MHC c1ass-I of MHC class-I antigen on the cell surface. as determined by antigen in a series of human cell lines produced after transfor-RIA and FACS analysis, generally reflected total cellular levels mation with either Ad 12 or Ad 5 EI DNA. I,, addition, the as determined by Western blotting. Expression of p2 microwas also much reduced in those cell lines with low effect on MHC of substituting the activated N-ras gene for the levels of M H C class-I antigen. The treatment of primary cells and all the transformants with human y-interferon resulted in increased expression of HLA on the cell surface. Infection of primary human cells with Ad I 2 or with a series of Ad I2 mutants did not have any effect on the MHC class-I antigens Virus infections present.
Primary human embryo kidney cells (HEKs) were grown on 9 cm plastic Petri dishes in Dulbecco's modified Eagle's me-Class-I major histocompatibility complex (MHC) antigens dium (DME) supplemented with 10% FCS. Cells were inare glycoproteins present on the surface of almost all mam-fected with Ad 12 wild-type or mutant viruses at 50 and 200
๐ SIMILAR VOLUMES
Tumor cells frequently show a lack of surface class-I major histocompatibility complex (MHC) antigen expression. These molecules are key recognition structures for immune rejection of tumor cells and their absence at the surface of tumor cells could favor the progression of tumors. We have analyzed
HLA class I molecules present antigenic peptides to cytotoxic T lymphocytes and thus play an important role in immune surveillance of cells infected with virus or altered by malignant transformation. Immunochemical studies have demonstrated a marked deficiency or lack of expression of class I molecu
We analyzed the expression of class-I antigens in ex vivo human tumor cells by isoelectric focusing (IEF) the anti-class-I mAb W6/32 immunoprecipitates prepared from cell lysates. Out of 42 experiments, 27 were technically successful. The patient's blood lymphocytes were used as controls. In vitro e
Peripheral blood lymphocytes (PBL) of 4 patients with malignant effusions were stimulated for 6 days with purified autologous tumour cells, before isolation of the lymphoblasts and cloning by limiting dilution in interleukin-2 (IL-2). Forty-five clones were analyzed for cytotoxicity (CTX) against au
In order to develop an effective immunotherapy for hematological malignancies, we investigated the applicability of class II transactivator (CIITA), which had been demonstrated to regulate the expression of MHC class II (MHC-II) by assembling the transcription factors of MHC-II molecules, for immuno